← Eichor
Study identifier: NCT05507853 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Exploring Central Sensitization in Pregnant Women

Condition: Pelvic Girdle Pain · Chronic Pain  ·  Sponsor: Göteborg University

PhaseN/A
Planned participants144
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersYes

About this study

Pelvic Girdle Pain (PGP) is reported by 50% of pregnant women and up to 11 years after pregnancy, 10% of women have persistent and per definition chronic PGP. Central (nervous system) sensitization that elicits pain hypersensitivity, may be one explanation. The overall aim of this study is to explore features of central sensitization in pregnant women and its predictive ability on physical activity, functioning and health in women with PGP. Measurements of central sensitization will be done on two study groups, pregnant women with PGP and healthy controls. To identify women at risk to develop chronic pain in relation to a common pain experience ie PGP in pregnancy, may help us understand if central sensitization early in life explains why women develop chronic pain.

This description comes directly from the study's public registry record.

Talk to the study team

Annelie Gutke, associate professor  ·  0046(0)7665747  ·  annelie.gutke@gu.se

Sonia Coelho Cristovao, PhD-student

Always discuss trial participation with your own doctor first.

Locations (1)

Närhälsan GibraltargatanGothenburg, SwedenRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05507853